University of Michigan at Antibody Engineering 2026
Dec 13–16, 2026 San Diego, CA ~900 attendees Website
University of Michigan takes part in 2 sessions at Antibody Engineering 2026 in San Diego. Its program covers how to pick drug candidates that will be easy to develop, and uses of antibodies beyond cancer. Its research uses dual-targeted carriers called oligoshuttles that lower gene activity in nerve cells after being given outside the nervous system.
| Organization | Antibody Engineering 2026 Attendance |
|---|---|
University of Michigan Ann Arbor, MI | |
Public research university in Ann Arbor, Michigan. | Chair Sun Dec 13 1:00pm–1:15pm Talk Tue Dec 15 3:00pm–3:30pm Dual-targeted Oligoshuttles Mediate Efficient Reduction of Neuronal Gene Expression after Peripheral Administration Antibodies that grab two receptors to cross into the brain and deliver gene-silencing strands into nerve cells. Bispecifics & multispecifics |
Find decision makers at University of Michigan
Tell us what you sell and we’ll find the people at University of Michigan most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by Antibody Engineering & Therapeutics, its organizers or The Antibody Society. Submit a correction